Factors associated with drug survival on first biologic therapy in patients with rheumatoid arthritis: a population-based cohort study

MLA

Ilan Green, et al. “Factors Associated with Drug Survival on First Biologic Therapy in Patients with Rheumatoid Arthritis: A Population-Based Cohort Study.” Rheumatology International, vol. 41, Sept. 2021, pp. 1905–13. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....3ca6185a025a3269717dfef1965dc8c8&authtype=sso&custid=ns315887.

APA

Ilan Green, Fadi Hassan, Mohammad E. Naffaa, Eugene Merzon, Avivit Golan-Cohen, Amir Saab, & Ziv Paz. (2021). Factors associated with drug survival on first biologic therapy in patients with rheumatoid arthritis: a population-based cohort study. Rheumatology International, 41, 1905–1913.

Chicago

Ilan Green, Fadi Hassan, Mohammad E. Naffaa, Eugene Merzon, Avivit Golan-Cohen, Amir Saab, and Ziv Paz. 2021. “Factors Associated with Drug Survival on First Biologic Therapy in Patients with Rheumatoid Arthritis: A Population-Based Cohort Study.” Rheumatology International 41 (September): 1905–13. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....3ca6185a025a3269717dfef1965dc8c8&authtype=sso&custid=ns315887.